Abbott Laboratories · NYSE:ABT

Vanguard Capital Management LLC reported a 7.50% stake in Abbott Laboratories (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 29, 2026

Vanguard Capital Management LLC reported a 7.50% stake in Abbott Laboratories, 130,676,776 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).

Stake
7.50%
Shares
130,676,776
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management7.50%130,676,776

Source

View original at SEC

Related